Group One Trading
AEMD icon

Group One Trading’s Aethlon Medical AEMD Stock Holding History

Group One Trading’s Portfolio AEMD Stock Details AEMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-1
Closed -$9K – 7956
2021
Q4 		$9K Hold
1
– – ﹤0.01% 7382
2021
Q3 		$19K Buy
+1
New +$16.8K ﹤0.01% 7194

Other funds holding AEMD

HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
SC
Shay Capital New York $1.56B AUM 46.17% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SRL
Scientech Research LLC Jersey City, New Jersey $123M AUM 198.31% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

Group One Trading's AEMD Position: Q2 2026 in Review

Group One Trading held its Aethlon Medical (AEMD) position steady in Q2 2026 at 3 shares worth $12. The position accounts for ﹤0.01% of the portfolio, ranked #7447.

Group One Trading first reported a position in AEMD in Q1 2022 and has held it in 18 quarters since. The position peaked at $29K in Q1 2022. 15 funds tracked by Wall St. Rank hold AEMD as of Q2 2026.

  • Group One Trading held 3 shares of Aethlon Medical worth $12 as of Q2 2026.
  • Group One Trading left its Aethlon Medical share count unchanged in Q2 2026.
  • Aethlon Medical made up ﹤0.01% of Group One Trading's portfolio in Q2 2026, its #7447 holding.
  • Group One Trading first reported a position in Aethlon Medical in Q1 2022 and has held it in 18 quarters since.
  • Group One Trading's Aethlon Medical position peaked at $29K in Q1 2022.
  • 15 funds tracked by Wall St. Rank held Aethlon Medical as of Q2 2026.

Based on Group One Trading's 13F filing for Q2 2026, filed 14 Aug 2026.